# A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients

> **NCT04048811** · PHASE2 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 46 (actual)

## Conditions studied

- Induction and Maintenance of General Anesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol
- **DRUG:** Propofol HSK3486

## Key facts

- **NCT ID:** NCT04048811
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-09
- **Primary completion:** 2020-05-23
- **Final completion:** 2020-06-22
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04048811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04048811, "A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04048811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*